Resverlogix Management
Management criteria checks 2/4
Resverlogix's CEO is Don McCaffrey, appointed in Apr 2003, has a tenure of 21.58 years. directly owns 1.88% of the company’s shares, worth CA$289.48K. The average tenure of the management team and the board of directors is 12.5 years and 14.6 years respectively.
Key information
Don McCaffrey
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 21.6yrs |
| CEO ownership | 1.9% |
| Management average tenure | 12.5yrs |
| Board average tenure | 14.6yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$11m |
| Jun 30 2024 | n/a | n/a | -US$11m |
| Mar 31 2024 | n/a | n/a | -US$10m |
| Dec 31 2023 | n/a | n/a | -US$17m |
| Sep 30 2023 | n/a | n/a | -US$13m |
| Jun 30 2023 | n/a | n/a | -US$10m |
| Mar 31 2023 | n/a | n/a | -US$6m |
| Dec 31 2022 | US$940k | US$373k | -US$4m |
| Sep 30 2022 | n/a | n/a | -US$21m |
| Jun 30 2022 | n/a | n/a | -US$25m |
| Mar 31 2022 | n/a | n/a | -US$27m |
| Dec 31 2021 | US$772k | US$400k | -US$25m |
| Dec 31 2020 | n/a | n/a | US$2m |
| Oct 31 2020 | n/a | n/a | US$4m |
| Jul 31 2020 | n/a | n/a | US$108m |
| Apr 30 2020 | US$2m | US$363k | US$118m |
| Jan 31 2020 | n/a | n/a | US$49m |
| Oct 31 2019 | n/a | n/a | US$31m |
| Jul 31 2019 | n/a | n/a | -US$109m |
| Apr 30 2019 | US$1m | US$377k | -US$163m |
| Jan 31 2019 | n/a | n/a | -US$110m |
| Oct 31 2018 | n/a | n/a | -US$121m |
| Jul 31 2018 | n/a | n/a | -US$92m |
| Apr 30 2018 | US$539k | US$393k | -US$58m |
Compensation vs Market: Insufficient data to establish whether Don's total compensation is reasonable compared to companies of similar size in the UK market.
Compensation vs Earnings: Don's compensation has increased whilst the company is unprofitable.
CEO
Don McCaffrey
21.6yrs
Tenure
US$939,744
Compensation
Mr. Donald J. McCaffrey, also known as Don, is a Co-Founder of Resverlogix Corporation and has been its Chief Executive Officer, President since April 25, 2003 and has also been its Chairman of the Board s...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Financial Officer | 15.1yrs | US$366.91k | 0.53% CA$ 82.2k | |
| Chief Scientific Officer | 2.3yrs | US$229.18k | 0.024% CA$ 3.7k | |
| Senior Vice President of Clinical Development | 10yrs | US$496.10k | 0.055% CA$ 8.5k | |
| Co-Founder | 21.6yrs | US$939.74k | 1.88% CA$ 289.5k |
12.5yrs
Average Tenure
Experienced Management: 0VF9's management team is seasoned and experienced (12.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 21.6yrs | US$939.74k | 1.88% CA$ 289.5k | |
| Independent Director | 14.2yrs | US$7.71k | 0.038% CA$ 5.9k | |
| Independent Director | 4.9yrs | US$34.88k | no data | |
| Lead Independent Director | 15.1yrs | US$57.48k | 0.037% CA$ 5.8k |
14.6yrs
Average Tenure
Experienced Board: 0VF9's board of directors are seasoned and experienced ( 14.6 years average tenure).